[HTML][HTML] Role of favipiravir in the treatment of COVID-19

S Joshi, J Parkar, A Ansari, A Vora, D Talwar… - International Journal of …, 2021 - Elsevier
… The Russian Government approved favipiravir for the treatment of COVID-19, on the basis
of encouraging early readouts from ongoing open-label randomized adaptive design clinical …

The regrettable story of the “Covid Kit” and the “Early Treatment of Covid-19” in Brazil

L Furlan, B Caramelli - The Lancet Regional Health–Americas, 2021 - thelancet.com
… a prophylaxis and early treatment medication against Covid-19 by the “Front Line COVID-19
Critical Care (FLCCC) Alliance,” an American medical organisation created in early 2020. …

Treatment for COVID-19: An overview

C Stasi, S Fallani, F Voller, C Silvestri - European journal of pharmacology, 2020 - Elsevier
… The results of the study suggest starting remdesivir treatment earlyearly stages of COVID-19,
one or a combination of antiviral agents could be used as a prophylactic or early treatment

Therapy for early COVID-19: a critical need

PS Kim, SW Read, AS Fauci - Jama, 2020 - jamanetwork.com
… , are under investigation for early treatment of COVID-19. These investigations have not
yet … Examples of antivirals in trials for early treatment of COVID-19 are MK-4482 (EIDD-2801), …

Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France

M Million, JC Lagier, P Gautret, P Colson… - Travel medicine and …, 2020 - Elsevier
… and AZ are the two most effective treatments among available therapies for COVID-19 [18].
Here, we report a retrospective evaluation of 1061 new COVID-19 patients, treated for at least …

[PDF][PDF] Remdesivir for the treatment of Covid-19-preliminary report

JH McMahon, A Udy, AY Peleg - The New England journal of …, 2020 - research.monash.edu
… recommends treatment with a single … treatment within 48 hours after the onset of illness.We
hypothesize that, on the basis of the results of the trial conducted by Beigel et al., much earlier

Early treatment for Covid-19 with SARS-CoV-2 neutralizing antibody sotrovimab

A Gupta, Y Gonzalez-Rojas, E Juarez… - … England Journal of …, 2021 - Mass Medical Soc
… of Covid-19 in high-risk patients early in the … coronavirus disease 2019 (Covid-19) during
the global pandemic. In the United States alone, an estimated 960,000 to 2.4 million Covid-19–…

Effect of early treatment with ivermectin among patients with Covid-19

G Reis, EASM Silva, DCM Silva… - … England Journal of …, 2022 - Mass Medical Soc
… of the efficacy of repurposed treatments for Covid-19 among adult outpatients at high risk for
… Brazil in order to simultaneously test potential treatments for early Covid-19 with the use of a …

Emerging treatment strategies for COVID-19 infection

M Gavriatopoulou, I Ntanasis-Stathopoulos… - Clinical and …, 2021 - Springer
… However, the trial was halted early due to the decrease in COVID-19 patients in China during
the study period, which could have contributed to the study being underpowered to detect …

Early treatment with pegylated interferon lambda for Covid-19

G Reis, EAS Moreira Silva… - … England Journal of …, 2023 - Mass Medical Soc
treatments, we examined the effect of pegylated interferon lambda on the composite outcome
of Covid-19–… in time to death or hospitalization due to Covid-19 (hazard ratio, 0.59; 95% …